Navigation Links
Director of Commerce, Rogers Weed, Presided Over Ribbon Cutting Ceremony Celebrating Opening of Expanded Manufacturing Facility at CMC Biologics
Date:9/22/2011

SEATTLE and COPENHAGEN, Denmark, Sept. 22, 2011 /PRNewswire/ -- CMC Biologics officially marked the opening of its state-of-the-art biopharmaceutical manufacturing facility, known as PF2, with a ribbon cutting ceremony on Wednesday, September 21, at its Bothell, Washington campus. The expansion of PF2 duplicates capacity and supports commercial manufacturing. Local political and business leaders attended the event.

(Photo: http://photos.prnewswire.com/prnh/20110922/SF73700)

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

Director of Commerce of Washington State, Rogers Weed, who presided over the dedication of the facility said, "I'm delighted to see Washington State's life sciences sector grow and expand. This region benefits in many ways from companies like CMC Biologics, which manufactures clinical and commercial materials for companies throughout the world. This is an industry that will provide the people of Washington State with jobs and prosperity into the next century."

According to David Kauffmann, Chairman of the Board of CMC Biologics and Managing Director of European Equity Partners, "Our vision has always been to be a global market leader in contract biopharmaceutical process development and manufacturing services. This facility expansion represents one more step toward making that vision a reality."

"We are proud of the positive impact of this project on the local economy. CMC Biologics used mainly local contractors for the expansion and once the facility is operating at full capacity, we anticipate adding about 35 new employees to staff it," noted Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics. "I'd like to thank our contractors as well as all of the employees at CMC Biologics who were instrumental in bringing this project in on time and on budget."

The expansion project was led by Yonkers Industries, with support from Sellen, BMWC Constructors, Holaday-Parks, and Precision Electric Group, as well as other subcontractors.

About CMC Biologics

CMC Biologics (www.cmcbio.com) is a dedicated contract biopharmaceutical manufacturing and development organization with facilities in Copenhagen, Denmark and Seattle, Washington, USA. CMC Biologics specializes in custom services for scale up and cGMP manufacture of protein-based therapeutics for preclinical, clinical trials, and in-market production. The Company's fully integrated services includes cell line development using its proprietary CHEF1® system, process and formulation development, and comprehensive analytical testing. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers stirred tank and perfusion production processes.


'/>"/>
SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors
2. Preetha Reddy, Managing Director, Apollo Hospitals Invited to United Nations Summit on NCDs
3. Rod Wolford Joins LABSCO Board of Directors
4. Gentris Corporation Announces Changes to Board of Directors
5. PTCB Board of Governors Announces Executive Director/CEO Murer Corrigan to Leave Organization
6. Stereotaxis Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
7. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
8. Hospira Expands Board of Directors
9. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
10. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
11. Genelux Corporation Appoints Catherine J. Mackey, PhD to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Research and Markets has announced the addition of the ... (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, ... HIV/AIDS etc.), Forecast to 2022" report to their offering. ... US ... clinical lab testing, which has evolved as a major source ...
(Date:1/21/2017)... , Jan. 20, 2017  Today, ... Symposia Conference, "PI3K Pathways in Immunology, Growth ... (NASDAQ: INFI ) presented ... development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). ... to help overcome resistance to checkpoint inhibition ...
(Date:1/20/2017)... 2017 Research and Markets has announced ... Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company ... ... Hearing Aids Market Sales Volume, Company Analysis and Forecast to ... aid industry. The growing prevalence of hearing impairment ...
Breaking Medicine Technology:
(Date:1/23/2017)... California (PRWEB) , ... January 23, 2017 , ... Old ... principles, has added Mr. Olympia Classic Physique bodybuilder Breon Ansley to its growing team ... competing as a bodybuilder in 2012 and in less than a year was able ...
(Date:1/23/2017)... ... , ... “The Inn at the Mill”: a story of love and redemption, hope and ... happy and content. , “The Inn at the Mill” is the creation of published ... Vermont and is now living in Berks County on Crow Hill. The inn, ...
(Date:1/23/2017)... , ... January 23, 2017 , ... “Life Under Blankets”: ... depression from an early age. “Life Under Blankets” is the creation of published author, ... Illinois, Circle Campus in Chicago. She went on to pursue a master’s degree in ...
(Date:1/22/2017)... ... ... Phytocéane invites clients to take an exotic journey deep into the heart ... CREAM. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the coast of ... to create this gentle, velvety body cream to envelop the skin in moisture while ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
Breaking Medicine News(10 mins):